Joanne Kenen
Showing 1–6 of 6 transcripts.
- Milken Institute1h 0m
Mental Health Innovations for the 21st Century
Joanne Kenen, LaTese Briggs, Arjun Desai, Kabir Nath, Richard Pops
A diverse panel of experts analyzed the pandemic's multifaceted impact on mental health, highlighting the rise of new crises among isolated populations and the limitations of telemedicine for complex addiction cases. Industry leaders and policymakers discussed critical reforms needed to address skewed pharmaceutical incentives, fund community-based workers, and shift corporate priorities toward genuine employee well-being. The discussion concluded with a consensus that lasting systemic change requires overhauling reimbursement models and increasing workforce diversity to support a post-pandemic world where mental health adaptation becomes permanent.
- Milken Institute1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Catherine Connolly, Michael Golinkoff
A panel of public health leaders and industry executives from organizations including DC Greens, CVS, and Socially Determined defined social determinants of health as critical external factors like housing and food security that drive clinical outcomes. The discussion highlighted actionable case studies, such as DC Greens' Produce Rx program and CVS's expansion of health hubs, which utilize data analytics to prove return on investment and shift SDOH interventions from philanthropic pilots to core business strategies. Participants emphasized that future success requires multisector coalitions to move beyond simple referrals toward shared accountability models that address systemic root causes while leveraging new value-based care incentives.
- Milken Institute57 min
Turning Back Time: The Science of Aging
Joanne Kenen, Nir Barzilai, Howard Fillit, Christopher Hite, Joan Mannick, Joanne Cannon, Sami, Aditi Ramdurai, San, Sarah Locke
A panel of experts led by Nir Barzilai, Christopher Healy, Howard Federoff, and Joan Manik is advocating for a paradigm shift in geroscience from treating individual chronic conditions to targeting the underlying biology of aging. The group is pursuing "healthspan compression" through concrete initiatives like the TAME metformin trial, TORC1 inhibitor development, and combination therapies designed to delay multiple diseases simultaneously. While regulatory hurdles and ethical concerns regarding long-term drug use remain, these efforts aim to prove that extending healthy life is economically viable and socially transformative.
- Milken Institute1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Katherine Connelly, Michael Golinkoff
Moderated by Joanne Cannon, a panel of public health leaders and corporate strategists redefined the conversation around Social Determinants of Health by prioritizing the business case for intervention over traditional philanthropy. Speakers detailed scalable models such as DC Greens' produce prescription program and CVS's integrated health hubs, which leverage data-driven insights to prove cost savings through medication compliance and reduced emergency room visits. The group concluded that sustainable growth depends on transitioning funding from grants to payer reimbursement within value-based care systems, leveraging political and corporate influence to address root causes like housing instability.
- Milken Institute58 min
Women's Health: Addressing Disparities from Health Leadership to Patient Care
Joanne Kenen, Janine Austin Clayton, Isabella Danel, Freda Lewis-Hall, Saralyn Mark, Paula Schneider
A panel of high-level health leaders from Pfizer, NIH, and the Susan G. Komen foundation highlighted the persistent gap between women's 57% share of U.S. healthcare expenses and their underrepresentation as decision-makers in clinical research. Participants argued that moving beyond a narrow reproductive focus to a holistic model addressing social determinants like violence and poverty requires integrating sex and gender data into all phases of biomedical innovation, from drug trials to medical device design. The group concluded that achieving equity demands structural changes, including formal male sponsorship, expanded parental leave, and the adoption of gendered innovations to ensure health systems serve diverse populations effectively.
- Milken Institute57 min
Reimagining Medicare for Longer Lives
Joanne Kenen, Efrem Castillo, Nancy-Ann DeParle, Terry Fulmer, Darilyn Moyer, John, Saira, Corinne Purtill
This panel discussion analyzes the structural misalignment between the US healthcare system's acute-care origins and the modern demographic reality of an aging population living longer with chronic conditions. While bipartisan legislation and private sector innovations in Medicare Advantage are successfully shifting incentives toward value-based care and addressing social determinants, implementation is severely hindered by astronomical administrative burdens and fragmented health IT interoperability. Participants conclude that future progress requires integrating social services into medical models and leveraging private sector experimentation to streamline the transition away from volume-based reimbursement.